Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| fibroblast | 19 studies | 22% ± 8% | |
| pericyte | 15 studies | 22% ± 6% | |
| basal cell | 13 studies | 29% ± 14% | |
| smooth muscle cell | 11 studies | 23% ± 6% | |
| connective tissue cell | 8 studies | 25% ± 9% | |
| epithelial cell | 8 studies | 30% ± 16% | |
| secretory cell | 6 studies | 22% ± 8% | |
| myofibroblast cell | 5 studies | 20% ± 2% | |
| endothelial cell | 5 studies | 20% ± 5% | |
| abnormal cell | 4 studies | 30% ± 10% | |
| respiratory goblet cell | 3 studies | 26% ± 12% | |
| mesothelial cell | 3 studies | 37% ± 22% | |
| epithelial cell of proximal tubule | 3 studies | 19% ± 3% | |
| club cell | 3 studies | 24% ± 4% | |
| ciliated cell | 3 studies | 28% ± 2% | |
| Mueller cell | 3 studies | 21% ± 5% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 4 studies | 27% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| ovary | 100% | 4813.39 | 180 / 180 | 100% | 124.53 | 430 / 430 |
| thymus | 100% | 5636.69 | 653 / 653 | 100% | 153.37 | 603 / 605 |
| uterus | 100% | 6726.64 | 170 / 170 | 99% | 146.41 | 453 / 459 |
| skin | 100% | 5594.21 | 1809 / 1809 | 97% | 163.24 | 459 / 472 |
| kidney | 100% | 4959.28 | 89 / 89 | 96% | 120.92 | 867 / 901 |
| bladder | 100% | 4519.90 | 21 / 21 | 95% | 121.20 | 480 / 504 |
| esophagus | 100% | 4873.71 | 1445 / 1445 | 95% | 82.57 | 173 / 183 |
| lung | 100% | 3522.64 | 576 / 578 | 94% | 111.19 | 1091 / 1155 |
| pancreas | 99% | 2123.20 | 325 / 328 | 95% | 111.92 | 169 / 178 |
| breast | 100% | 4523.95 | 459 / 459 | 92% | 93.78 | 1034 / 1118 |
| liver | 100% | 2349.68 | 225 / 226 | 93% | 81.90 | 376 / 406 |
| prostate | 100% | 4711.67 | 245 / 245 | 89% | 47.77 | 448 / 502 |
| brain | 94% | 1654.56 | 2485 / 2642 | 94% | 90.59 | 660 / 705 |
| intestine | 100% | 3519.97 | 964 / 966 | 87% | 85.60 | 457 / 527 |
| stomach | 97% | 2309.79 | 350 / 359 | 84% | 70.38 | 241 / 286 |
| adrenal gland | 100% | 4115.55 | 258 / 258 | 38% | 24.01 | 87 / 230 |
| adipose | 100% | 4054.48 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 5631.46 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 251.61 | 80 / 80 |
| spleen | 100% | 2059.02 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 132.37 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 95.58 | 1 / 1 |
| heart | 95% | 1997.42 | 817 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 83% | 48.30 | 24 / 29 |
| peripheral blood | 38% | 826.16 | 350 / 929 | 0% | 0 | 0 / 0 |
| muscle | 18% | 172.56 | 146 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0007165 | Biological process | signal transduction |
| GO_1901224 | Biological process | positive regulation of non-canonical NF-kappaB signal transduction |
| GO_0043009 | Biological process | chordate embryonic development |
| GO_0030335 | Biological process | positive regulation of cell migration |
| GO_0048041 | Biological process | focal adhesion assembly |
| GO_0001725 | Cellular component | stress fiber |
| GO_0005856 | Cellular component | cytoskeleton |
| GO_0005829 | Cellular component | cytosol |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005925 | Cellular component | focal adhesion |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0019900 | Molecular function | kinase binding |
| GO_0046966 | Molecular function | nuclear thyroid hormone receptor binding |
| GO_0005149 | Molecular function | interleukin-1 receptor binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0046872 | Molecular function | metal ion binding |
| GO_0003723 | Molecular function | RNA binding |
| Gene name | TRIP6 |
| Protein name | Thyroid receptor-interacting protein 6 (TR-interacting protein 6) (TRIP-6) (Opa-interacting protein 1) (OIP-1) (Zyxin-related protein 1) (ZRP-1) Thyroid hormone receptor interactor 6 |
| Synonyms | OIP1 |
| Description | FUNCTION: Relays signals from the cell surface to the nucleus to weaken adherens junction and promote actin cytoskeleton reorganization and cell invasiveness. Involved in lysophosphatidic acid-induced cell adhesion and migration. Acts as a transcriptional coactivator for NF-kappa-B and JUN, and mediates the transrepression of these transcription factors induced by glucocorticoid receptor. . |
| Accessions | ENST00000429658.1 ENST00000619988.4 [Q15654-3] ENST00000437505.5 [Q15654-3] H7BZE2 ENST00000417475.5 [Q15654-2] Q15654 ENST00000200457.9 [Q15654-1] |